![Michael Didocha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Didocha
Corporate Officer/Principal presso
TELIX PHARMACEUTICALS LIMITED
Profilo
Michael Didocha is currently the Chief Financial Officer-American Region at Telix Pharmaceuticals Ltd. He previously worked as a Finance Director at Roche Holding AG.
Mr. Didocha completed his undergraduate degree at Georgia Institute of Technology and holds an MBA from Kelley School of Business.
Posizioni attive di Michael Didocha
| Società | Posizione | Inizio |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 31/08/2021 |
Precedenti posizioni note di Michael Didocha
| Società | Posizione | Fine |
|---|---|---|
| ROCHE HOLDING AG | Direttore Finanziario/CFO | - |
Formazione di Michael Didocha
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
